http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0511234-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_499a6f1330f7827c5a14b8e0b76304d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8828412a08c427cf0e753b98d7339754
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
filingDate 1990-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0bd88913cc7bc2d6ae37d6e2c9dcac2
publicationDate 1992-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0511234-A1
titleOfInvention STABLE INJECTABLE SOLUTIONS BY FACTOR VIII.
abstract Stable solution for injection containing factor VIII or factor IX, suitable for treatment on humans, natural and synthetic disaccharides, preferably sucrose, in a concentration of between 0.1 and 0.65 mol / l, as well as one or more amino acids in a concentration between 0.1 and 1.0 m01 / 1. Process for the manufacture of this solution and the use of natural or synthetic disaccharides, preferably sucrose, and one or more amino acids for the stabilization of factors VIII or IX.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2921180-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021001522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022099223-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2193809-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2130554-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1820516-A2
priorityDate 1990-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100271720
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID85253
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403875
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5340
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00747
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67149
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID421580
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81286
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID733660
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80010
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12545
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80009
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R8X6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374258
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06867
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14069
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7M323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280897
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33574
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624995
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403602
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5ECE3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29485
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18783
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404015
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID359826
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID465887
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18815
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463117

Total number of triples: 94.